Repligen financials
$194.57+0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $738.3M | $634.4M | $632.4M | $801.5M | $670.5M | $366.3M | $270.2M | $194.0M | $141.2M | $104.5M |
| Gross profit | $386.2M | $274.6M | $278.4M | $455.7M | $391.3M | $209.6M | $151.1M | $107.5M | $74.2M | $57.4M |
| Gross margin | 52.3% | 43.3% | 44.0% | 56.9% | 58.3% | 57.2% | 55.9% | 55.4% | 52.5% | 54.9% |
| Operating income | $55.2M | -$35.1M | $47.7M | $224.7M | $167.2M | $69.8M | $36.1M | $26.0M | $14.0M | $16.0M |
| Net income | $48.9M | -$25.5M | $35.6M | $186.0M | $128.3M | $59.9M | $21.4M | $16.6M | $28.4M | $11.7M |
| Net margin | 6.6% | −4.0% | 5.6% | 23.2% | 19.1% | 16.4% | 7.9% | 8.6% | 20.1% | 11.2% |
| Diluted EPS | $0.86 | $-0.46 | $0.63 | $3.24 | $2.24 | $1.11 | $0.44 | $0.37 | $0.72 | $0.34 |
| EBITDA | $135.5M | $34.6M | $117.5M | $246.9M | $211.6M | $96.9M | $57.0M | $41.8M | $24.5M | $24.6M |
| Operating cash flow | $117.4M | $175.4M | $113.9M | $172.1M | $113.2M | $62.6M | $67.2M | $32.8M | $17.5M | $7.5M |
| Free cash flow | $93.9M | $149.7M | $77.7M | $87.2M | $46.1M | $40.2M | $48.7M | $22.1M | $12.0M | $3.2M |
| Diluted shares | 56.6M | 55.9M | 56.4M | 57.5M | 57.3M | 53.9M | 49.2M | 45.5M | 39.2M | 34.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $566.0M | $757.4M | $751.3M | $523.5M | $603.8M | $717.3M |
| Short-term investments | $201.6M | $0.00 | $0.00 | $100.3M | $0.00 | — |
| Total debt | $542.2M | $525.6M | $579.6M | $284.6M | $255.3M | $243.7M |
| Total assets | $2.95B | $2.83B | $2.83B | $2.53B | $2.36B | $1.90B |
| Total liabilities | $843.6M | $856.9M | $866.3M | $620.9M | $608.3M | $373.7M |
| Shareholders' equity | $2.11B | $1.97B | $1.96B | $1.91B | $1.75B | $1.53B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology